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Abstract
After infection, extralymphoid tissues are enriched with effector and memory T cells of a highly activated phenotype. The
capacity for rapid effector cytokine response from extralymphoid tissue-memory T cells suggests these cells may perform a
‘sentinel’ function in the tissue. While it has been demonstrated that extralymphoid CD4+ T cells can directly respond to
secondary infection, little is known about how rapidly this response is initiated, and how early activation of T cells in the
tissue may affect the innate response to infection. Here we use a mouse model of secondary heterosubtypic influenza
infection to show that CD4
+ T cells in the lung airways are reactivated within 24 hours of secondary challenge. Airway CD4
+
T cells initiate an inflammatory cytokine and chemokine program that both alters the composition of the early innate
response and contributes to the reduction of viral titers in the lung. These results show that, unlike a primary infection,
extralymphoid tissue-memory CD4
+ T cells respond alongside the innate response during secondary infection, thereby
shaping the overall immune profile in the airways. These data provide new insights into the role of extralymphoid CD4
+ T
cells during secondary immune responses.
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Introduction
In recent years it has become clear that extralymphoid tissues
play an important role in the adaptive immune response by
harboring primed T cells following infection or immunization,
many of which have an effector phenotype [1,2,3,4]. In animal
models of viral infection, effector-memory cells can be recovered
from non-lymphoid tissues for several months. As a result, it has
been proposed that these cells accumulate in extralymphoid tissues
to act as a first line of defense in case of secondary challenge with
the same or antigenically related virus [5,6]. Indeed, it has been
shown that primed T cells can be very cross-reactive between
infections, suggesting an even more plausible role for extralym-
phoid cells in site-specific immune protection [7,8]. In support of
this model, several recent reports have demonstrated that
extralymphoid memory T cells can be reactivated by secondary
infection, and contribute to immune protection [9,10,11,12].
In particular, we recently described a unique population of
tissue-memory CD4
+ T cells recovered from the lungs of influenza
immune mice [4]. These local memory cells could be distinguished
from their effector memory counterparts in both function and cell
surface phenotype, including the expression of the integrin VLA-1.
In earlier work, we demonstrated that inhibition or deletion of the
alpha chain of VLA-1 leads to a substantial loss of immune
protection from secondary challenge [13]. While we attributed
most of this effect to a decrease in virus-specific CD8
+ T cells in
the airways, we did not address the contribution of airway memory
CD4
+ T cells to the protective response. Given the recent
identification of a highly functional VLA-1
+ tissue-memory CD4
+
T cell subset, and the importance of having memory T cells in the
airways in models of secondary influenza challenge, we sought to
better understand the in vivo contributions and behavior of these
local memory T cells.
Extralymphoid CD4
+ T cells may play several roles in their
contribution to secondary immunity, ranging from acting as helper
cells in the tissue for induction of a protective extralymphoid CD8
response [12] to a direct role as effector cells in elimination of virus
[14]. While these studies confirmed the ability of extralymphoid
CD4
+ T cells to respond during secondary infection, they were
focused on time points several days after the start of the infection,
making it unclear whether the observations reflect the contribu-
tions of recently recruited cells from either the circulation or
lymphoid sites, or instead reflect the action of those memory T
cells in the tissue at the start of infection.
Woodland and colleagues proposed a phased model of the
secondary adaptive immune response, consisting of a rapid and
early response from tissue-resident cells, followed by accumulation
of antigen non-specific cells drawn into the tissue via inflamma-
tion, and then accumulation of expanded secondary effector cells
prior to pathogen clearance [15]. If this model were correct, the
initial phase would be occurring simultaneous to the early innate
immune response, leaving open the possibility that there is
interaction between the two. A recent report by the Swain lab
has furthered our understanding of the early tissue response by
demonstrating CD4-dependent alterations in the lung innate
inflammatory cytokine milieu in the first two days of secondary
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innate cytokines was antigen-dependent, the resulting ‘protective
state’ induced in the tissue was independent of infection or PAMP
recognition, suggesting memory CD4
+ T cells in the lung were
able to orchestrate the early innate response.
Here, we used a model of heterosubtypic influenza infection to
study the reactivation of CD4
+ T cells present in the lung airways
at the time of secondary challenge. Our results show that it takes at
least three days for newly expanded secondary T cells to arrive in
the airway. In contrast, airway CD4
+ T cells are reactivated within
24 hours of secondary challenge. Infection induces transcriptional
changes in airway CD4
+ T cells, including the up-regulation of a
panel of inflammatory chemokines and cytokines, as well as the
anti-inflammatory cytokine IL-10. Early innate responses are
consequently altered compared to primary infection, likely due to
the local early adaptive response. These results demonstrate the
sentinel function of airway memory CD4
+ T cells during
secondary influenza infection, and suggest that the combined
effects of early innate and adaptive tissue responses contribute to
secondary immune protection.
Results
Airway memory CD4
+ T cells decline in numbers but
express CD69 during early secondary infection
In order to study the kinetics of early secondary infection, we
utilized a mouse model of heterosubtypic immunity with
recombinant influenza viruses that contain the OVA323–339
epitope recognized by TCR transgenic OT-II cells [17,18]. This
allowed the parallel monitoring of primed endogenous CD4
+ and
OT-II cells during secondary infection. Our initial prediction was
that CD4
+ cell recovery by BAL would rapidly increase as
infection-induced inflammation caused the recruitment of second-
ary effector cells. Surprisingly, we measured a decline in the
recovery of CD44
hi CD4
+ T cells by BAL in the first three days of
secondary infection that did not rebound until day 5 (Fig. 1A). The
recovery of OT-II cells in the first five days of secondary infection
also followed similar kinetics (Fig. 1C). Interestingly, we observed
an increase in the proportion of CD69
+ cells in the BAL as early as
24 hours post-infection, and nearly 60% of BAL CD4
+ T cells
were CD69
+ at 48 hours (Fig. 1E). This finding raised the question
whether the CD69
+ cells were newly recruited from circulation, or
airway tissue-memory cells responding to infection. To address
this, we compared the phenotype, function and proliferation of
CD4
+ T cells in various organs during secondary infection.
CD69
+ CD4
+ T cells are present in the airways before the
accumulation of proliferating cells
Throughout the first five days of secondary infection, there was
a modest three-fold increase in CD4
+ cell recovery from the
draining mediastinal lymph node (MLN) (Fig. 1B). In contrast,
OT-II cell recovery from MLN increased by ,20-fold (Fig. 1D),
which was consistent with published results of the secondary
expansion potential of memory CD4+ T cells [19]. To measure
proliferation and airway accumulation of CD4
+ T cells in response
to secondary infection, we used two approaches. The first was to
pulse recovered animals with 59-bromodeoxyuridine (BrdU) and
monitor the appearance of divided CD4
+ T cells in various organs
during secondary infection. Figure 2 shows that the proportion of
BrdU
+ CD4
+ T cells in all organs studied did not increase above
that seen in unchallenged memory animals until three or more
days after secondary challenge. On day 3 forward, the proportion
of BrdU
+ CD4
+ T cells in the MLN increased, coinciding with the
recovery of BrdU
+ cells by BAL (Fig. 2A, B). We interpret these
observations to indicate that there is limited if any secondary
expansion of reactivated CD4
+ memory T cells in the airway, and
that CD4
+ memory cells from the draining lymph node begin
expanding from day 2 forward before they reach the lung.
Airway memory cells present at the time of secondary
infection are phenotypically distinct from the
subsequent influx of circulating cells
The second approach to studying cellular dynamics, particularly
in BAL, took advantage of some of the unique properties of airway
T cells. First, T cells in the airways are continually replaced by
circulating memory cells at a steady rate [20]. Second, activated
LFA-1
hi T cells down-regulate both chains of the integrin LFA-1
(aL/CD11a and b2/CD18) in a time-dependent manner after
migration to the airways [20]. One observation that is a
consequence of this phenomenon is that primed CD4
+ T cells
recovered by BAL one month post-infection have a uniquely
broad distribution of CD11a expression (Fig. S1), presumably
reflecting a mixture of recently recruited CD11a
hi cells as well as
memory T cells that have been there longer and have progressively
lost integrin expression as a function of time in the tissue. During a
rapid influx of T cells from the circulation, we would expect to
recover a greater proportion of CD11a
hi cells by BAL compared to
unchallenged memory animals. Interestingly, the proportion of
CD11a
hi cells in the BAL remained unchanged for the first
48 hours of secondary infection (Fig. 2E), even though CD69
increased (Fig. 1E) among these cells. It was not until day 3 on that
CD4
+ T cells with a CD11a
hi phenotype began to predominate, a
time consistent with the appearance of BrdU
+ cells in both BAL
and MLN. Indeed, two-dimensional plots of BrdU and CD11a
showed that almost all BrdU
+ CD4
+ T cells recovered by BAL
were CD11a
hi (Fig. 2F). Throughout secondary infection, all CD4
+
T cells in the spleen were CD11a
hi (Fig. S1). These observations
reinforce the idea that CD4
+ tissue-memory T cells are reactivated
in the airways, but newly recruited cells from outside the airways
take three or more days to appear.
We also compared the effector cytokine profile of memory and
secondary CD4
+ T cells by detection of IFN-c, IL-2 and TNF-a
following ex vivo restimulation. BAL samples from resting memory
and re-challenged mice were co-cultured with peptide-loaded
splenic APCs from naı ¨ve mice in the presence of Brefeldin A.
Intracellular accumulation of IFN-c, IL-2 and TNF-a was
detected simultaneously in responder cells via multicolor flow
cytometry. Single cytokine producers were identified as making
only one of the three cytokines, while double producers made any
combination of two out of three. The frequency of single, double,
and triple cytokine-producing CD4
+ T cells from the airways was
similar in cells recovered from unchallenged memory animals and
one day after secondary challenge (Fig. 2G). However, a greater
proportion of double cytokine-producing cells were recovered by
BAL seven days post-infection (Fig. 2G), suggesting that resident
memory cells and those from the influx of secondary effector cells
in the circulation differ in their composition of effector functions.
Taken together, these data demonstrate that at least two distinct
phases of the secondary response in the lung airways are separable
based on kinetics, cell phenotype and turnover. The first phase
largely consists of CD4
+ T cells present in the airways at the time
of infection. Significant increases in CD69 expression occur in this
population within 24 hours of secondary infection, and limited
proliferation is observed. In contrast, the second phase is
dominated by CD11a
hi cells, many of which have divided. Our
results do not necessarily distinguish whether these cells begin
dividing locally or in the lymphoid tissues, and recent reports
suggest that some local proliferation may be possible [11,21]. In
Airway Memory CD4
+ T Cell Response to Influenza
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+ T cells in
the airways until day 3 forward.
Airway tissue-memory CD4
+ T cells respond to secondary
infection within 24 hours
The identification of a distinct population of airway memory
CD4
+ T cells present during the first two days of secondary infection
allowed us to determine whether this population was reactivated by
infection.Totestthis,we highlypurified endogenousairwayCD4
+T
cells from a cohort of mice that were either challenged with a
secondary influenza infection or left unchallenged. After flow
cytometric sorting, we analyzed RNA expression of multiple genes
by RT-PCR. The total dataset is in Figure 3, and the subset of genes
that were significantly different between memory and secondary
airway CD4
+ T cells are in Table 1. Compared to cells from the
unchallenged mice, airway CD4
+ T cells recovered within 24 hours
of secondary infection had induced a variety of inflammatory genes
consistent with their reactivation to infection (Fig. 3 and Table 1).
Theprofileofinducedgeneswasroughlywhatwouldbeexpectedfor
aT H1 cell response in the airway, including genes for IFN-c
inducible chemokines and cytolytic granule proteins. However, we
also found a concomitant increase in the anti-inflammatory cytokine
IL-10 (Table 1). These data suggest reactivated TH1c e l l sm a ys e l f -
regulate inflammation via IL-10 secretion in a similar fashion as
airway CD4
+Tcellsthatarepresentduringtheresolutionofprimary
influenza infection [22]. Alternatively, distinct populations of CD4
+
T cells may be responding during the early airway response, focused
both on directing antiviral inflammation and reducing pathology.
The rapid reactivation of CD4
+ T cells in the airways raised the
question as to the nature of the re-activating antigen-presenting
cell. Recent published data has shown that antigen presentation in
the lung provides an important activating signal for effector T cells
during primary infection [23,24]. In addition, data from the Heath
lab suggests a CD4-CD8-dendritic cell interaction can occur in the
Figure 1. Kinetics of CD4
+ cell recovery and CD69 expression during secondary influenza infection. OT-II cells were intravenously
transferred to mice that were subsequently infected with H1N1 WSN-OVAII. One month after infection, a secondary infection with H3N2 X-31/OVAII
was given to a cohort of recovered mice. At several time points post-infection, BAL and MLN samples were collected, and CD4
+ T cells identified as
CD44
hi CD4
+ T cells within the lymphocyte gate. OT-II cells identified as CD4
+ Thy1.1
+. A–D) Recovery of CD4
+ T cells after secondary infection. Graphs
show CD44
hi CD4
+ (A–B) or CD4
+ Thy1.1
+ (C–D) cells from BAL (A, C) or MLN (B, D). E) Percentage of BAL CD44
hi CD4
+ T cells expressing CD69 during
secondary infection. Data are representative of three experiments, +/2SEM of n=3–12 per point. *=p,0.05; #=p,0.01 compared to day 0 data
within same group.
doi:10.1371/journal.pone.0020493.g001
Airway Memory CD4
+ T Cell Response to Influenza
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studied the innate cells recovered by BAL 18 hours post-secondary
infection, and used an antibody to influenza nucleoprotein as a
means of detecting cells carrying intracellular viral antigen. We
found Gr-1
+ and CD11c
+ cells were the two major cell types from
BAL that stained positive for viral nucleoprotein (Fig. 4A–B). Since
about two-thirds of the recovered CD11c
+ cells were MHC class
II
+ and ,1% of Gr-1
+ cells were class II
+ (not shown), these data
suggest CD11c
+ lung dendritic cells are likely capable of
presenting viral antigens to local CD4
+ T cells during the early
stage of secondary infection.
The composition of the lung innate cell response is
altered during secondary infection
One contribution of virus-specific memory T cells in the airways
is a modification of the local inflammatory response [16]. In
further analysis, we discovered profound differences in the
recovery of several lymphoid and myeloid cell populations from
the airways comparing primary and secondary influenza infection
(Fig. 4C–E). In the early stages of infection, there was increased
recovery of CD11c
+ Class II
hi cells and CD3
2 NK1.1
+ cells
compared to primary infection, while total Gr-1
+ cells were
reduced, and CD11b
+ CD11c
2 cells were unchanged (Fig. 4 and
Figure 2. Proliferation and phenotype of memory CD4
+ T cells during secondary infection. A–D) Mice were infected with WSN-OVAII.A t
one month post-infection, half of the mice were given heterosubtypic secondary infection, and the other half left uninfected. On the day of
secondary infection, both memory and secondary mice were administered BrdU i.p., and supplemented with BrdU water thereafter. Mice were
sacrificed at several time points, and cells were recovered from BAL, MLN, non-draining lymph node (NDLN) and spleen (SPL). Data shown are the
proportion of BrdU
+ cells amongst the CD44
hi CD4
+ cell subset in either secondary (black) or memory (white) mice. *=p,0.05; #=p,0.01 compared
to day 1 values within same group. E) Percentage of BAL CD44
hi CD4
+ T cells expressing CD11a during secondary infection. #=p,0.01 compared to
day 0. F) Representative two-dimensional plots of CD11a and BrdU staining of BAL CD44
hi CD4
+ T cells on day 0 (d0), 1, 3, and 5 post-secondary
infection. G) Pie charts depicting multiple cytokine producing response of BAL CD44
hi CD4
+ T cells from memory or secondary mice producing IL-2,
IFN-c and/or TNF-a following ex vivo re-stimulation. Data are representative of two experiments, +/2SEM of n=4–5 individual mice per experiment
(n=8–10 total).
doi:10.1371/journal.pone.0020493.g002
Airway Memory CD4
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+ Class II
hi
cells, there was an increased proportion of cells expressing CD80/
86, as well as increased recovery of both CD11b
+ CD103
2 and
CD11b
2 CD103
+ dendritic cell populations 24 hr after secondary
infection compared to primary (Fig. S2) [25]. These differences in
innate cell recovery are likely independent of lung conditioning by
the primary infection, since mice given intranasal LPS treatment
(as a means of conditioning the lung) prior to influenza had similar
innate cell recoveries as mice given primary infection but not re-
challenged (not shown).
Role of CD4
+ T cells on the composition of the innate
response and lung viral titer during secondary infection
To assess whether CD4
+ T cells were important for the
observed changes in innate cell recovery, we treated immune
memory animals with GK1.5 antibody to CD4 prior to secondary
challenge. This resulted in a complete depletion of CD4
+ T cells
from lymphoid organs and substantial, but not complete depletion
from the lung (data not shown). During a 4-day period after
infection, we observed modest changes in the recovery of innate
cells by BAL in GK1.5-treated mice compared to controls that
were intermediate in value between mice with primary infection or
non-depleted controls (Fig. S3), suggesting local tissue-memory
CD4
+ T cells may alter the inflammatory cell milieu and play a
role in shaping the early innate response. However, since depletion
of CD4
+ T cells from the lung was incomplete, we cannot rule out
the contribution of residual CD4
+ memory T cells and/or a level
of redundancy between the airway CD4
+ and CD8
+ tissue
memory cell responses.
In order to compare GK1.5 and control-treated animals in their
capacity to control infection, viral titers were measured from BAL
supernatants of primary and secondary infected lungs. Viral titers
in GK1.5 and control-treated BAL were comparable one and two
days after secondary infection, with a trend towards an increased
titer in GK1.5-treated animals on day two (Fig. 5). On day four,
there was a significant decrease in viral titer in secondary infected
control mice compared to primary infection, and this decrease in
viral titer was lost in GK1.5 treated mice (Fig. 5), suggesting CD4
+
T cells contribute to the rapid viral clearance observed between
primary and secondary infection.
Figure 3. Transcriptional changes in BAL CD4
+ T cells during early secondary infection. Mice were given heterosubtypic infection as in
Figure 1. Another group of mice received primary infection but no secondary. At one or two days post-infection, BAL samples were pooled, and CD3
+
CD44
hi CD4
+ T cells were FACS sorted to .99% purity. RNA was isolated from sorted samples, and RT-PCR was used in a custom array format to
measure gene transcription. The data shown are heat map results comparing 24 hr and 48 hr time points with memory BAL. Fold change in relation
to memory BAL is segmented into colors, and the color legend is described at the top of the figure. Each rectangle represents an individual gene, and
the heat map legend is at the bottom of the figure. Results are an average of n=4–5 per group per time point; each n is a pool of BAL from 25–30
mice.
doi:10.1371/journal.pone.0020493.g003
Airway Memory CD4
+ T Cell Response to Influenza
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In summary, these studies demonstrate rapid responsiveness of a
local population of CD4
+ T cells in the lung airway at the time of
secondary infection. Airway cells respond 24-48 hours prior to the
appearance of divided secondary effectors, and turn on an
inflammatory response program that promotes reduced viral titers
and may help shape the developing innate response. After the first
two days of infection, a second phase of divided cells can be
detected that differ in both functional and cell surface phenotypes.
This report, in conjunction with previous reports demonstrating
antigen non-specific accumulation of primed T cells during
infection [11,17,26,27], provides further support for the multi-
phase model of adaptive immune responsiveness to secondary
infection.
In order to understand the overall immune response to
secondary contact with a pathogen, it is important to first identify
when and where the different populations of immune cells
participate in the response. Here we have carefully documented
the reactivation, timing, phenotype, and gene expression profiles
of the flu-specific memory CD4
+ T cells in the airways. We have
previously shown that the CD4
+ T cells in the airways of immune
mice are functionally distinct from those in the lymphoid organs
and are comprised of at least two populations differentiated by
alpha-1 integrin expression and reactivation potential [4]. Mice
that are deficient in alpha-1 integrin demonstrate increased
susceptibility to secondary virus challenge [13] but have no
defects in a primary response to non-lethal influenza challenge.
The diminished protection has been associated with a reduction in
the number of virus-specific memory T cells present in the lung at
the time of re-challenge, and is also observed in wild-type mice
after longer time intervals [13,28,29,30]. Although much of this
loss of protection has been attributed to cytotoxic CD8
+ T cells
[13,29,30], local CD4
+ memory T cells are also present. The data
presented herein shows that these cells are activated and
participate in the response, potentially by modifying the
inflammatory response and/or directly contributing to reduction
in lung viral titer.
One outstanding question not addressed in this report is the
proportion of airway memory T cells that respond to secondary
infection in vivo. While a high proportion of virus-specific T cells
respond in ex vivo restimulation, whether reactivation is uniform in
vivo remains to be determined. The specific localization of
memory cells within the lung and airway environment may be
important. For example, data from our laboratory suggest airway
CD4
+ and CD8
+ cells expressing the a1b1 integrin VLA-1 may
be uniquely positioned for secondary responsiveness due to the
capacity of VLA-1
+ cells to localize near large airways [4,31].
Presumably, localization within the airway epithelium is a critical
feature of rapid and effective immune function. While it is easy to
appreciate the potential for cytotoxic CD8
+ T cells to engage
class I MHC on infected epithelial cells, the mechanisms by
which CD4
+ T cells are reactivated remain less clear. While our
data suggests that professional antigen-presenting cells bearing
influenza antigen are more numerous in immune mice, it is
possible that both antigen-specific responses driven via class II
MHC interactions, as well as antigen non-specific responses via
inflammatory cytokines [11,32] could result in multiple antigen
specific and non-specific T cell populations responding in concert
during early infection.
We discovered profound differences in the cellular composition
of the lung innate response to secondary infection compared to
primary infection. While it seems clear from our data and others
[16] that local adaptive memory can shape the early tissue
response, it is unclear how these changes in the lung affect the
outcome of infection. For instance, in analysis of cytokine
secretion from endogenous airway memory CD4
+ T cells, we
found a significant increase in IL-10 expression during secondary
infection. This was in association with a decreased recovery of
granulocytes compared to primary infection, consistent with
published data on Gr-1
+ cells in IL-10
2/2 mice after bleomycin-
induced lung injury or fungal infection [33,34]. In addition, aged
mice have been shown to have increased levels of IL-10, which
appears to reduce innate responses in the lung [35]. These data
suggest that increased IL-10 production from CD4
+ T cells may
limit the granulocyte response during secondary infection.
However, depletion of memory CD4
+ T cells in our studies not
only alters the contribution of memory CD4
+ T cells themselves
to secondary immune protection, but also the CD4-induced
changes in the local innate inflammatory and cellular environ-
ment. It would be useful to have a system in which memory
CD4
+ T cells established by respiratory infection are the only
cross-reactive T cell subset, though such a system does not
currently exist. With such a system, it may be possible to further
segregate the relative contributions of adaptive memory and the
altered innate response in protection.
Our results complement a recent report showing increased
innate inflammatory cytokine secretion in the lung during
Table 1. BAL CD4+ cell transcriptional changes after
secondary infection.*
24 hours 48 hours
Gene Product Fold change
# Gene Product Fold change
#
Cxcl10 CXCL10 117.4 Gzmb Granzyme B 75.1
Gzmb Granzyme B 32.2 Cxcl10 CXCL10 52.5
Cxcl11 CXCL11 31.7 Il10 IL-10 38.1
Cxcl9 CXCL9 15.3 Cxcl11 CXCL11 29.1
Il10 IL-10 11.7 Ccl4 CCL4 21.1
Ccl4 CCL4 5.9 Ccl7 CCL7 20.7
Prf1 Perforin 3.3 Cxcl9 CXCL9 16.1
Il12rb1 IL-12Rb1 3.3 Ccl2 CCL2 11.8
Stat1 STAT1 2.9 Ccl3 CCL3 6.5
Tnfsf10 TRAIL 1.6 Prf1 Perforin 4.6
Ifngr1 IFN-cRI 21.5 Il12rb1 IL-12Rb13 . 7
Cxcr3 CXCR3 21.6 Bcl2 BCL-2 22.5
Bax BAX 21.8 Cxcl12 CXCL12 2123.0
Itgb1 Integrin b1 21.9
Bcl2 BCL-2 22.0
Tnfrsf1a TNFRI 22.0
Itgb2 Integrin b2 22.0
Il23 IL-23 22.2
Itga4 Integrin a4 22.3
Cxcr6 CXCR6 22.7
Cd40Ig CD40L 23.0
Cxcl12 CXCL12 2121.2
Ccl24 CCL24 2756.1
Il3 IL-3 23952.7
*Identified as p,0.01 compared to memory BAL values (see Materials and
Methods).
#Fold change in secondary BAL CD4+ gene expression compared to memory.
doi:10.1371/journal.pone.0020493.t001
Airway Memory CD4
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memory CD4
+ T cells themselves to the early inflammatory
environment, and suggest that airway memory cells present at the
time of infection, rather than circulating memory cells recruited to
the lung, are responsible for the early changes observed. We also
show that, coupled with changes in innate inflammatory cytokines,
innate cell recovery is significantly altered by the presence of an
adaptive tissue response, and may be the result of CD4
+ T cell
reactivation. We propose that rapidly responding extralymphoid
tissue memory cells have the capacity to shape changes in the
composition of the local innate response that result in a greater
capacity for viral clearance and regulation of immune pathology.
Further investigation into the protective and pathogenic roles of
extralymphoid memory cells will give greater understanding of
their importance in immune protection.
Materials and Methods
Animals
C57Bl/6 and B6.SJL mice were purchased from the National
Cancer Institute. T cell receptor transgenic OT-II mice [36] on
the B6.PL background (gift from Dr. Linda Bradley) were bred
and maintained at the University of Rochester Medical Center in
specific pathogen-free conditions. All animals were ethically
handled in compliance with the University of Rochester
Institutional Biosafety Committee guidelines.
Viral infection
Influenza virus stocks of A/HKx31, A/HKx31/OVAII (gift
from Dr. Richard Webby [18]) and A/WSN-OVAII [17] were
thawed from 280uC and diluted in sterile PBS prior to use.
Figure 4. Comparison of primary and secondary innate responses in the lung. A) BAL cells from memory (white bars) or 18 hr post-
secondary (black bars) mice were stained intracellularly with antibody to influenza nucleoprotein (NP) on dendritic cells (MHC class II
+ CD11c
+), B cells
(CD11c
2 CD11b
2 Class II
+ B220
+), Granulocytes (Gr-1
+ CD11b
+) and lymphocytes (CD11c
2 Gr-1
2 CD3e
+). Percentages indicate the proportion of each
population that was NP-positive. #=p,0.01 compared to memory data within same group. B) Staining for NP in the CD11c
+ MHC Class II
+ cells
collected from memory (dashed line) and secondarily infected (solid line) BAL. C–E) Cell recovery of MHC Class II
+ CD11c
+ cells (C), Gr-1
+ CD11b
+ cells
(D), and NK1.1
+ DX5
+ CD11c
+ CD3e
2 MHC Class II
2 cells (E) from BAL and lung of mice after primary (diamonds) or secondary (squares) infection. The
average NK cell numbers for day 1 are 11 and 68 for primary and secondary, respectively, with p=0.02. The average BAL DCs on day 1 are 55 vs. 348,
p=0.006; and lung is 3200 vs. 6400, p=0.03. Data are representative of 3 experiments, +/2SEM of n=3–5 per data point. *=p,0.05; #=p,0.01
comparing primary and secondary data on same day.
doi:10.1371/journal.pone.0020493.g004
Airway Memory CD4
+ T Cell Response to Influenza
PLoS ONE | www.plosone.org 7 May 2011 | Volume 6 | Issue 5 | e20493Recipient mice were first sedated with avertin (2,2,2-tribromoeth-
anol) i.p., then given a 30 ml intranasal inoculation of virus.
Organ collection
Mice were administered a lethal dose of Avertin by intraper-
itoneal injection and exsanguinated via the brachial artery.
Bronchoalveolar lavage (BAL) samples were collected by three
intratracheal lung washes (with C-mem) using a Teflon canula
attached to a 1 ml syringe. Lung tissue, MLN and spleen were
removed separately. For lymphocyte analysis, BAL samples were
subjected to 45 min. plastic adherence prior to use; for innate cell
analysis, this step was skipped. Lung tissue was minced with
scissors, then ground in a tea strainer. Resulting homogenate was
incubated with 0.05% type IV collagenase (Sigma) and 0.003%
DNase I (Sigma) for 60 min. at 37uC. Cells were washed, re-
suspended in HBSS, and lymphocytes isolated by Histopaque
1083 (Sigma) underlay and centrifugation. MLN and spleen were
homogenized and filtered through nylon mesh. All organ cells
were maintained in C-mem prior to use.
Flow cytometry
The following antibodies were used in surface and intracellular
staining procedures: IL-2/FITC, NK1.1/FITC, IFN-c/PE,
CD69/PerCP-Cy5.5, CD11a/PE-Cy7, CD11c/PE-Cy7, TNF-
a/APC, BrdU/APC, B220/APC, Gr-1/APC-Cy7 and CD11b/
biotin purchased from BD; MHC Class II I
A/I
E/PE-Cy5,
CD62L/APC-Cy7 and CD4/Alexa 700 purchased from
eBioscience; DX5/PE and CD44/Pacific Blue purchased from
Biolegend; streptavidin-Pacific Orange purchased from Invitro-
gen. Surface staining: 1-2610
6 cells from each organ were placed in
individual wells of a 96-well round-bottom plate for staining. Fc
receptors were blocked with anti-CD16/32 (clone 2.4G2, from
BD) for 15 min. Cells were washed and surface stained with
various antibodies from the above list, diluted in PBS/BSA and
incubated for 30 min. at room temperature. Cells were washed
before analysis.
Intracellular staining. spleen cells from naı ¨ve B6.SJL
(CD45.1
+) mice were used as APCs and infected with influenza
(MOI=1) in 1 ml serum-free media for 60 min. Infected cells
were then washed and resuspended in C-mem. 1610
6 APCs were
added to 1610
6 responders (prepared as described above). Golgi
Plug (BD) was then diluted 1 ml/ml in C-mem and 100 ml added
to each well. Cells were incubated for 5–6 hr at 37uC. Samples
were then surface stained as described above. Samples were
washed and resuspended in 100 ml/well Cytofix/Cytoperm (BD)
for 15 min. After one Perm/Wash (BD), anti-cytokine antibodies
were added in Perm/Wash, and cells incubated for 30 min. on ice
in the dark. Samples were resuspended in PBS/BSA for FACS.
Detection of incorporated Bromodeoxyuridine (BrdU).
Cohorts of mice were administered 1 mg BrdU per mouse by i.p.
injection at day 0. For the duration of the experiment, mice were
maintained on BrdU-enriched water at a concentration of
0.5 mg/ml. After cell recovery from animals, followed by surface
staining and permeabilization, the APC anti-BrdU kit (BD) was
used to detect BrdU
+ DNA in cells. In short, fixed and
permeabilized cells were incubated with Cytoperm Plus buffer to
permeabilize nuclei, and then treated a second time with Cytofix/
Cytoperm for re-fixation of cells. Cells were then treated with
DNase to expose BrdU, and subsequently stained with APC anti-
BrdU for detection via cytometry. Gating of BrdU
+ cells was
determined by parallel staining of cells that did not receive BrdU
in the experiment as a negative staining control. All FACS was run
on an LSRII flow cytometer (BD), and analyzed using FlowJo
software (Treestar).
Figure 5. Impact of CD4
+ T cells on viral titers during secondary infection. BAL supernatants from memory, secondary infected, and GK1.5-
treated secondary infected mice were injected into embryonated chicken eggs for determination of viral titers (see Materials and Methods). Samples
from day 1, 2, and 4 post-secondary infection (with X-31 virus) were compared +/2 GK1.5 treatment, with primary X-31 infection as control. Mean and
SEM from the n=3–4 mice per time points per group are indicated by the horizontal bar symbols and in the inset figure. A Kruskal-Wallis rank test
was performed, with significant p values shown.
doi:10.1371/journal.pone.0020493.g005
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For detection of gene transcription, custom microfluidics cards
were purchased from Applied Biosystems containing 96 unique
genes in a 384-well format.
Sample collection. One month after A/WSN infection, a
cohort of mice were given an X-31 secondary infection. BAL
samples were collected from three groups: memory, 24 hr post-
secondary, and 48 hr post-secondary. Pools of BAL cells (BAL
pooled from 25–30 mice for each data point) were processed and
surface stained. Cells were then sorted with a FACSAria cell sorter
(BD) by CD3
+ CD4
+ CD44
hi staining to .99% purity. Sorted cells
were washed, lysed using RLT buffer (Qiagen), spun through
Qiashredder columns (Qiagen), and stored at 280uC. All steps
were done cold to limit RNA degradation. RNA isolation and
quality control was performed by the University of Rochester
Functional Genomics core (Rochester, NY). Samples were run
using a 7900HT Real time PCR system (Applied Biosystems).
Housekeeping genes (Gapdh, 18s RNA, b-actin) were compared
between memory and secondary samples to ensure comparable
expression between groups. Obtained RQ values for each gene
were then compared across replicates and groups to determine
fold changes in gene expression. No fold cutoff filter was used after
statistical analysis. Data was analyzed using SDS software (ABI)
and Excel (Microsoft).
Viral titers
Infection of eggs. BAL supernatants were initially diluted
1:10 in PBS/gentamycin, and a ten-fold dilution series was made
from this. 100 ml of each sample dilution was injected into a ten
day incubated viable chicken egg beneath the air pocket. Each
sample dilution was done in triplicate. The egg injection site was
sealed with wax and the eggs placed in a static incubator at 37uC
for 48 hours. The eggs were then removed and placed at 4uC for
.24 hours.
Hemagglutination assay. 50 ml of PBS was added to each
well of round-bottom 96-well plates, allowing 2 wells per egg, and
including positive control wells of virus on each plate. Using a glass
pipette, allantoic fluid was withdrawn from each egg and 100 ml
was added to the appropriate wells on the 96-well plate.
Concurrently, chicken red blood cells were washed in PBS three
times and resuspended at 1:100 in PBS. 50 ml of diluted chicken
RBCs was added to each well. The plates were allowed to incubate
for 30 min at room temperature. The wells were read as positive
or negative depending on lysis of the chicken RBCs. A calculation
was performed to determine EID50 for each sample.
Statistics
Standard analyses. For comparison of sets of unpaired data,
two-tailed T test was used. Resulting p values ,0.05 were
considered significant.
Analysis of RT-PCR data. Permutation test was used to
detect differentially expressed genes in BAL cell populations after
secondary infection. Permutation test was performed on the log2
scale, (log2(RQ)) comparing memory BAL to secondary BAL.
Taking into account both Bonferroni correction and control of
per-family error rate [37] to deal with the inflated study-wide type
I error due to multiple comparisons, p values ,0.01 were
considered significant. For comparisons of cell number and virus
titers among the groups, unpaired, non-parametric Wilcoxon or
Kruskal-Wallis rank tests were performed.
Supporting Information
Figure S1 Comparison of CD11a profiles in BAL and
spleen. Representative histograms depicting CD11a profiles of
CD44
hi CD4
+ T cells from BAL and spleen during the first five
days of secondary infection. Data are representative of 3
experiments, n=3–5 per time point.
(TIFF)
Figure S2 Comparison of airway dendritic cell popula-
tions between primary and secondary influenza infec-
tion. 24 hr after primary or secondary influenza infection, cells
were recovered and stained by flow cytometry. The proportion of
lung Class II
+ CD11c
+ dendritic cells expressing both CD80 and
CD86 (A), as well as the number of BAL CD11b
+ CD103
2 and
CD11b
2 CD103
+ populations among Class II
+ CD11c
+ cells (B)
was determined. Data are +/2 SEM of n=4 per group. In (A),
#=p,0.01. In (B), *=p,0.05 comparing primary and second-
ary groups.
(TIFF)
Figure S3 Effect of GK1.5 administration on secondary
lung innate cell recoveries. A–C) Mice were given a primary
WSN infection or nothing. One month post-infection, half of the
immune mice were administered GK1.5 to deplete CD4
+ T cells.
All mice were infected with X-31 two days after antibody
administration. Innate cell recovery of dendritic cells, granulocytes
and NK cells by BAL were determined by flow cytometry as in
Figure 4. Data are representative of 2 experiments, +/2SEM of
n=3–5 per data point. *p,0.05 comparing primary to secondary
and secondary GK1.5 treated groups.
(TIFF)
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